Last updated on April 2016

Miglustat on Gaucher Disease Type IIIB


Brief description of study

evaluate the combination therapy with Miglustat and enzyme replacement therapy (ERT) on Gaucher disease

Detailed Study Description

understand if Miglustat (glucosylceramide synthase inhibitor) could improve neuropathy in patients with Gaucher disease

Clinical Study Identifier: NCT02520934

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Yin-Hsiu Chien, M.D., Ph.D.

National Taiwan University Hospital
Taipei, Taiwan
  Connect »